Urge Urinary Incontinence - Poor Differentiation Limiting New Product Uptake

Questions: Discounts, Updates etc.

Price: $15,200.00

Publication Date: 2006-04-14

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Urge urinary incontinence (UUI) is a relatively common disorder which can affect all age groups but becomes increasingly prevalent with old age. Although several pharmacological therapies are available for treating this distressing condition, patients' reluctance to present to a physician and incorrect diagnosis of the different overactive bladder subtypes limit the potential of this market.


Scope

  • Quantitative treatment data from 418 physicians based in US, Japan, France, Germany, Italy, Spain and UK; supported by key opinion leader comments
  • Analysis of epidemiology, presentation and referral patterns, diagnostic assessment, and first- to third-line treatments for UUI
  • Influences on treatment choice and perception of current drug therapies including tolterodine, oxybutynin, darifenacin and solifenacin
  • Evaluation of unmet needs and future outlook including awareness of R&D drug pipeline


    • Report Highlights
    Although the prevalence of UUI in women is high, the potential of this market is limited by the reluctance of patients to present to a physician for treatment. Direct to consumer advertising, where available, has already increased awareness and presentation of this condition but other strategies are also required to assist in enlarging the market.

    In theory, UUI could be managed successfully by PCPs. However, there is little belief in their ability to correctly diagnose the subtypes of OAB and this lack of confidence is supported by inappropriate prescribing trends by PCPs. Methods to address diagnosis and treatment of UUI in the primary care setting should reflect the priorities of PCPs.

    Older treatments for UUI are associated with a number of unpleasant side effects, leaving significant unmet need in this market. Several new products have recently entered the market yet there is little perceived differentiation from existing treatments. Emphasizing the improved efficacy and side effect profiles is key to improving uptake.


    Reasons to Purchase

  • Forecast product sales by understanding key aspects of UUI epidemiology, diagnosis and treatment
  • Gain a better understanding of the challenges facing current and future players in the UUI market
  • Identify physicians key concerns in UUI including unmet needs and the attributes that physicians believe are desirable for future treatments

    • Table of Contents

    Other users found this report page using the following search terms: incontinence overactive bladder urge incontinence stress incontinence incontinence urge urinary treatment ppt powerpoint overactive stress bladder bladderppt

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.